1-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine → HCID 66616512, Verbindung

HRID 1914224Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1914224
[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([C:17]2[C:18]([CH3:24])([CH3:23])[C:19](=[O:22])[NH:20][N:21]=2)[CH:12]=[CH:13][C:14]=1[O:15][CH3:16])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CC1C=CC(S(O[CH:36]2[CH2:41][CH2:40][N:39](C(OC(C)(C)C)=O)[CH2:38][CH2:37]2)(=O)=O)=CC=1>>[CH2:1]([O:8][C:9]1[CH:10]=[C:11]([C:17]2[C:18]([CH3:24])([CH3:23])[C:19](=[O:22])[N:20]([CH:36]3[CH2:41][CH2:40][NH:39][CH2:38][CH2:37]3)[N:21]=2)[CH:12]=[CH:13][C:14]=1[O:15][CH3:16])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Komponenten

3

Edukt 2

HCID 157347131-(tert-Butoxycarbonyl)-4-(p-toluenesulfonyloxy)piperidine2×HCID 666165693-[3-(benzyloxy)-4-methoxyphenyl]-4,4-dimethyl-4,5-dihydro-1H-pyrazol-5-one2×

Produkt 1

HCID 66616512HCID 66616512, Verbindung

Versuchsvorschrift

Prepared analogously as described for the example B1 (Alternative 1) using 5-[3-(benzyloxy)-4-methoxyphenyl]-4,4-dimethyl-2,4-dihydro-3H-pyrazol-3-one (compound C4) and tert-butyl 4-{[(4-methylphenyl)sulfonyl]oxy}piperidine-1-carboxylate (compound E1) as starting compounds resulting in the hydrochloride salt of the title compound. (compound B4*HCl)

Aufarbeitung

  1. customPrepared analogously

Quellen und Nachweise

ORD-Eintrag
ord-03700ba0a2eb40aba78b17244585c938
Quelldatensatz
uspto-grants-2013_12
Patentnummer
US08609848B2

Notizen zur Reaktion

Wird geladen…